retatrutide parkinson's disease clinical trial nct The NADPARK study: A randomized phase I of nicotinamide riboside supplementation in Current Therapies in Trials – retatrutide ly3437943 parkinson's disease clinical
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

























